title: Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
abstract: Bitopic binding properties apply to a variety of muscarinic compounds that span and simultaneously bind to both the orthosteric and allosteric receptor sites. We provide evidence that fluorescent pirenzepine derivatives, with the M1 antagonist fused to the boron-dipyrromethene [Bodipy (558/568)] fluorophore via spacers of varying lengths, exhibit orthosteric/allosteric binding properties at muscarinic M1 receptors. This behavior was inferred from a combination of functional, radioligand, and fluorescence resonance energy transfer binding experiments performed under equilibrium and kinetic conditions on enhanced green fluorescent protein-fused M1 receptors. Although displaying a common orthosteric component, the fluorescent compounds inherit bitopic properties from a linker-guided positioning of their Bodipy moiety within the M1 allosteric vestibule. Depending on linker length, the fluorophore is allowed to reach neighboring allosteric domains, overlapping or not with the classic gallamine site, but distinct from the allosteric indolocarbazole "WIN" site. Site-directed mutagenesis, as well as molecular modeling and ligand docking studies based on recently solved muscarinic receptor structures, further support the definition of two groups of Bodipy-pirenzepine derivatives exhibiting distinct allosteric binding poses. Thus, the linker may dictate pharmacological outcomes for bitopic molecules that are hardly predictable from the properties of individual orthosteric and allosteric building blocks. Our findings also demonstrate that the fusion of a fluorophore to an orthosteric ligand is not neutral, as it may confer, unless carefully controlled, unexpected properties to the resultant fluorescent tracer. Altogether, this study illustrates the importance of a "multifacet" experimental approach to unravel and validate bitopic ligand binding mechanisms.
authors.affiliation: Unité Biotechnologie et Signalisation cellulaire, UMR 7242 CNRS, Université de Strasbourg, Ecole Supérieure de Biotechnologie de Strasbourg, 300 Bvd S. Brant - BP 10413, 67412 Illkirch, France.
authors.forename: Sandrine B
authors.initials: SB
authors.lastname: Daval
authors.forename: Esther
authors.initials: E
authors.lastname: Kellenberger
authors.forename: Dominique
authors.initials: D
authors.lastname: Bonnet
authors.forename: Valérie
authors.initials: V
authors.lastname: Utard
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Galzi
authors.forename: Brigitte
authors.initials: B
authors.lastname: Ilien
mesh_terms: D000494:Allosteric Regulation; D000495:Allosteric Site; D001896:Boron Compounds / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D005456:Fluorescent Dyes / Q000494:pharmacology*; D005703:Gallamine Triethiodide / Q000494:pharmacology; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D008024:Ligands; D016297:Mutagenesis, Site-Directed / Q000379:methods; D009447:Neuroblastoma / Q000235:genetics / Q000378:metabolism; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D043643:Receptor, Muscarinic M1 / Q000235:genetics* / Q000378:metabolism*
chemical_list: C088337:Bodipy-pirenzepine; D001896:Boron Compounds; D005456:Fluorescent Dyes; D008024:Ligands; D043643:Receptor, Muscarinic M1; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D010890:Pirenzepine; D005703:Gallamine Triethiodide; D002118:Calcium